Fundamental Research Report: Tempus AI, Inc. (NASDAQ: TEM) ## Company Overview and Business Model Tempus AI, Inc. (NASDAQ: TEM) is a technology company focused on advancing precision medicine through the application of artificial intelligence (AI) in healthcare. The company’s core offerings include AI-driven diagnostics, data analytics platforms, and clinical trial matching services, primarily targeting oncology, cardiology, and infectious diseases. Tempus operates the Tempus Platform, which integrates clinical and genomic data to provide actionable insights for physicians, researchers, and biopharmaceutical companies. The company generates revenue through two primary segments: **Genomics** (diagnostic testing and sequencing services) and **Data and Services** (data licensing, analytics, and AI-driven solutions like Tempus One and xM). ### Revenue Streams 1. **Genomics (65% of revenue)**: Tempus provides molecular diagnostic tests, including next-generation sequencing (NGS) for c...
Financial freedom are most of the people thinking, however as a individual, can we share all our normal thinking with same interest group. Thus this blog is to share with people who are interested in talking about economy, wealth creation and fun of life